01 7Alecensa
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 902
2018 Revenue in Millions : 656
Growth (%) : 38
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 1,292
2019 Revenue in Millions : 976
Growth (%) : 32
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 1,459
2020 Revenue in Millions : 1,230
Growth (%) : 17
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 1,654
2021 Revenue in Millions : 1,459
Growth (%) : 13
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 1,743
2022 Revenue in Millions : 1,654
Growth (%) : -1
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 384
2016 Revenue in Millions : 193
Growth (%) : 99
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 643
2017 Revenue in Millions : 366
Growth (%) : 76%
LOOKING FOR A SUPPLIER?